JS
Jasper Therapeutics, Inc.
JSPRW · NASDAQ
$0.01 -93.75% (-$0.08)
1M -58.68%
Market Cap $81.3K
P/E Ratio -
Div. Yield -
ROE 618.87%
Bulios Fair Price
$0.01
100.0% upside
Trenutna cena
$0.005
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica JSPRW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.06x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 51.32%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 1,305.04%
Asset turnover 0.00x
ROE 618.87%
Debt
91 /100
Low Debt/Equity 0.19x
Current ratio 1.47x
Int. coverage N/A
Stability
44 /100
Moderate Beta 3.01x
Profitable years 0
EPS volatility 11.65%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JSPRW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeetinder Singh Mahal
Employees
22
Headquarters
Redwood City
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report